14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today ESPR ranks #17877 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

$3.77 (1.07%)

Volume: 926k

Closed: Jan 20, 2022

Hollow Logo Score: -4.942

Esperion Therapeutics Stock Forecast

$3.77 (1.07%)

Volume: 926k

Closed: Jan 20, 2022

Score Hollow Logo -4.942

Esperion Therapeutics Stock Price (Quote) NASDAQ:ESPR

$3.77 ( 1.07% ) Thursday, 20th Jan 2022

Range Low Price High Price Comment
30 days $3.61 $5.41 Thursday, 20th Jan 2022 ESPR stock ended at $3.77. This is 1.07% more than the trading day before Wednesday, 19th Jan 2022. During the day the stock fluctuated 6.43% from a day low at $3.73 to a day high of $3.97.
90 days $3.61 $10.83
52 weeks $3.61 $39.50

Historical Esperion Therapeutics prices

Date Open High Low Close Volume
2022-01-20 $3.76 $3.97 $3.73 $3.77 926 126
2022-01-19 $3.72 $3.81 $3.61 $3.73 995 203
2022-01-18 $3.87 $3.94 $3.72 $3.73 1 104 986
2022-01-14 $3.95 $4.02 $3.71 $3.93 1 463 507
2022-01-13 $3.98 $4.14 $3.87 $4.13 1 087 606
2022-01-12 $4.21 $4.23 $3.96 $3.99 1 097 680
2022-01-11 $4.08 $4.42 $4.01 $4.18 1 674 363
2022-01-10 $4.20 $4.20 $3.90 $4.03 1 387 495
2022-01-07 $4.36 $4.44 $4.13 $4.15 1 414 520
2022-01-06 $4.81 $4.89 $4.32 $4.37 2 147 000
2022-01-05 $4.95 $5.05 $4.71 $4.76 1 289 961
2022-01-04 $5.16 $5.28 $4.91 $4.97 970 342
2022-01-03 $5.05 $5.25 $4.84 $5.19 1 140 141
2021-12-31 $4.97 $5.06 $4.92 $5.00 819 898
2021-12-30 $4.79 $5.14 $4.79 $4.96 1 796 067
2021-12-29 $4.90 $4.97 $4.70 $4.81 1 550 554
2021-12-28 $5.06 $5.38 $4.85 $4.92 1 958 369
2021-12-27 $5.38 $5.38 $5.00 $5.07 1 658 254
2021-12-23 $5.15 $5.41 $5.09 $5.38 1 785 790
2021-12-22 $5.08 $5.15 $5.00 $5.15 1 261 177
2021-12-21 $5.20 $5.29 $5.05 $5.13 1 096 489
2021-12-20 $5.05 $5.19 $4.99 $5.16 1 256 907
2021-12-17 $5.18 $5.37 $5.12 $5.19 2 636 410
2021-12-16 $5.34 $5.44 $5.09 $5.15 1 345 463
2021-12-15 $5.00 $5.35 $4.85 $5.35 2 746 252
2021-12-14 $5.02 $5.28 $4.92 $5.02 1 873 987
2021-12-13 $5.17 $5.43 $4.88 $5.06 2 388 328
2021-12-10 $5.31 $5.45 $5.09 $5.17 1 872 260
2021-12-09 $5.74 $5.74 $5.28 $5.30 4 319 775
2021-12-08 $5.62 $5.91 $5.52 $5.87 3 186 829
2021-12-07 $5.72 $5.72 $5.39 $5.56 4 451 616
2021-12-06 $5.19 $5.65 $5.13 $5.61 6 068 406
2021-12-03 $6.09 $6.10 $4.96 $5.25 28 744 966
2021-12-02 $7.87 $9.13 $7.87 $8.97 2 114 547
2021-12-01 $8.75 $9.07 $8.04 $8.04 2 517 589
2021-11-30 $8.47 $9.05 $8.10 $8.73 2 585 234
2021-11-29 $7.90 $8.76 $7.59 $8.68 1 129 743
2021-11-26 $7.70 $7.83 $7.21 $7.78 1 289 087
2021-11-24 $8.49 $8.68 $7.50 $7.69 6 977 790
2021-11-23 $7.16 $10.02 $7.02 $10.02 4 894 800
2021-11-22 $7.48 $7.52 $6.97 $7.12 898 231
2021-11-19 $7.53 $7.94 $7.32 $7.41 1 158 387
2021-11-18 $7.82 $7.85 $7.23 $7.66 980 086
2021-11-17 $8.55 $8.55 $7.84 $7.87 895 021
2021-11-16 $8.59 $8.66 $8.34 $8.51 541 811
2021-11-15 $8.87 $8.98 $8.57 $8.72 839 361
2021-11-12 $9.20 $9.31 $8.77 $8.79 1 324 552
2021-11-11 $9.44 $9.57 $9.22 $9.26 927 430
2021-11-10 $9.74 $9.91 $9.50 $9.55 476 439
2021-11-09 $9.90 $10.20 $9.71 $9.84 1 106 159

About Esperion Therapeutics

Esperion Therapeutics Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of oral and low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of patients with elevated LDL-C. Its lead product candidate is ETC-1002 or Bempedoic acid, an inhibitor of ATP Citrate Lyase, an enzyme on the cholesterol biosynthesis pathway that is in Phase III long-term safety and tolerability study to... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT